(BN) Brookfield - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA11271J1075

Real Estate, Infrastructure, Renewables, Private Equity, Asset Management

BN EPS (Earnings per Share)

EPS (Earnings per Share) of BN over the last years for every Quarter: "2020-09": 0.1, "2020-12": 0.41, "2021-03": 0.77, "2021-06": 0.49, "2021-09": 0.47, "2021-12": 0.66, "2022-03": 0.81, "2022-06": 0.34, "2022-09": 0.85, "2022-12": -0.23, "2023-03": 0.05, "2023-06": 0.03, "2023-09": 0.73, "2023-12": 0.83, "2024-03": 0.77, "2024-06": 1.35, "2024-09": 0.0136, "2024-12": 0.2479, "2025-03": 0.0214, "2025-06": 0.8, "2025-09": 0,

BN Revenue

Revenue of BN over the last years for every Quarter: 2020-09: 16249, 2020-12: 17088, 2021-03: 16410, 2021-06: 18286, 2021-09: 19248, 2021-12: 21787, 2022-03: 21882, 2022-06: 23256, 2022-09: 23418, 2022-12: 24213, 2023-03: 23297, 2023-06: 23668, 2023-09: 24441, 2023-12: 24518, 2024-03: 22907, 2024-06: 23050, 2024-09: 20623, 2024-12: 19426, 2025-03: 17944, 2025-06: 18083, 2025-09: null,

Description: BN Brookfield

Brookfield Corporation (NYSE:BN) operates as a global alternative-asset manager and REIT-style real-estate investment manager, deploying capital across real estate, renewable power, infrastructure, and private-equity/venture-capital assets. It offers both public and private investment products to institutional and retail clients, leveraging its own balance-sheet alongside third-party capital to acquire large-scale, high-quality assets worldwide.

The firm’s private-equity platform targets a broad set of transaction types-including control buyouts, distressed acquisitions, carve-outs, recapitalizations, and mezzanine financings-across sectors that typically own tangible assets (e.g., industrial products, building materials, metals, mining, homebuilding, oil & gas, and packaging). In venture capital, Brookfield focuses on early-stage and growth-stage opportunities, while its infrastructure and renewable-power businesses concentrate on long-lived, cash-generating projects such as toll roads, utilities, and wind/solar farms.

Geographically, Brookfield’s investment universe spans North America (including the United States, Canada, and Brazil), Europe, Australia, and the Asia-Pacific region. Typical equity commitments range from $2 million to $500 million, with a standard investment horizon of four years, a ten-year fund life, and the option for two one-year extensions. The firm is comfortable taking either minority or majority stakes, depending on the strategic fit and control considerations.

As of FY 2023, Brookfield reported approximately **$950 billion** in assets under management (AUM), a **12 %** year-over-year increase driven largely by inflows into its renewable-energy platform and infrastructure funds. Revenue grew to **$31 billion**, with an operating margin of **28 %**, reflecting the high-yield, low-volatility nature of its core assets. Key macro drivers include rising global infrastructure spending (projected to exceed $15 trillion by 2030), accelerating demand for clean-energy capacity (global renewable-energy investment reached $1.1 trillion in 2023), and a relatively stable low-interest-rate environment that supports the firm’s dividend-focused REIT structure. However, any significant upward shift in rates could pressure the cost of capital for new acquisitions and affect the valuation of existing debt-heavy assets.

For a deeper, data-driven look at how Brookfield’s valuation metrics compare to peers and to assess the sensitivity of its cash-flow profile to macro-economic scenarios, you may find the analytics on ValueRay worth exploring.

BN Stock Overview

Market Cap in USD 102,118m
Sub-Industry Asset Management & Custody Banks
IPO / Inception 1983-12-30

BN Stock Ratings

Growth Rating 78.3%
Fundamental 36.3%
Dividend Rating 18.6%
Return 12m vs S&P 500 5.01%
Analyst Rating 3.78 of 5

BN Dividends

Dividend Yield 12m 0.79%
Yield on Cost 5y 2.05%
Annual Growth 5y -4.52%
Payout Consistency 96.2%
Payout Ratio 32.3%

BN Growth Ratios

Growth Correlation 3m 45.4%
Growth Correlation 12m 66.2%
Growth Correlation 5y 59.2%
CAGR 5y 30.68%
CAGR/Max DD 3y (Calmar Ratio) 1.10
CAGR/Mean DD 3y (Pain Ratio) 4.14
Sharpe Ratio 12m 0.89
Alpha -4.52
Beta 2.187
Volatility 31.83%
Current Volume 5092.3k
Average Volume 20d 3139k
Stop Loss 42.5 (-4.4%)
Signal 0.05

Piotroski VR‑10 (Strict, 0-10) 1.0

Net Income (841.0m TTM) > 0 and > 6% of Revenue (6% = 4.56b TTM)
FCFTA -0.00 (>2.0%) and ΔFCFTA 0.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 11.40% (prev -18.30%; Δ 29.71pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.02 (>3.0%) and CFO 10.19b > Net Income 841.0m (YES >=105%, WARN >=100%)
Net Debt (236.93b) to EBITDA (30.83b) ratio: 7.69 <= 3.0 (WARN <= 3.5)
Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (1.57b) change vs 12m ago 2.39% (target <= -2.0% for YES)
Gross Margin 31.50% (prev 18.45%; Δ 13.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 15.16% (prev 19.09%; Δ -3.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.22 (EBITDA TTM 30.83b / Interest Expense TTM 17.21b) >= 6 (WARN >= 3)

Altman Z'' 0.63

(A) 0.02 = (Total Current Assets 74.61b - Total Current Liabilities 65.93b) / Total Assets 506.07b
(B) 0.03 = Retained Earnings (Balance) 16.25b / Total Assets 506.07b
(C) 0.04 = EBIT TTM 21.01b / Avg Total Assets 501.69b
(D) 0.12 = Book Value of Equity 42.36b / Total Liabilities 344.42b
Total Rating: 0.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 36.34

1. Piotroski 1.0pt = -4.0
2. FCF Yield -0.36% = -0.18
3. FCF Margin -1.61% = -0.60
4. Debt/Equity 5.38 = -2.50
5. Debt/Ebitda 7.69 = -2.50
6. ROIC - WACC (= 1.29)% = 1.61
7. RoE 1.83% = 0.15
8. Rev. Trend -84.19% = -6.31
9. EPS Trend 13.61% = 0.68

What is the price of BN shares?

As of October 18, 2025, the stock is trading at USD 44.46 with a total of 5,092,285 shares traded.
Over the past week, the price has changed by +3.32%, over one month by -3.84%, over three months by -2.00% and over the past year by +21.26%.

Is Brookfield a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Brookfield (NYSE:BN) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 36.34 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BN is around 48.50 USD . This means that BN is currently overvalued and has a potential downside of 9.09%.

Is BN a buy, sell or hold?

Brookfield has received a consensus analysts rating of 3.78. Therefor, it is recommend to hold BN.
  • Strong Buy: 2
  • Buy: 5
  • Hold: 1
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the BN price?

Issuer Target Up/Down from current
Wallstreet Target Price 73.4 65.2%
Analysts Target Price 73.4 65.2%
ValueRay Target Price 52.5 18.1%

Last update: 2025-10-04 03:47

BN Fundamental Data Overview

Market Cap USD = 102.12b (102.12b USD * 1.0 USD.USD)
P/E Trailing = 154.9091
P/E Forward = 13.7741
P/S = 1.3045
P/B = 2.3994
Beta = 2.187
Revenue TTM = 76.08b USD
EBIT TTM = 21.01b USD
EBITDA TTM = 30.83b USD
Long Term Debt = 250.63b USD (from longTermDebt, last quarter)
Short Term Debt = 40.91b USD (from shortLongTermDebt, last quarter)
Debt = 250.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 236.93b USD (from netDebt column, last quarter)
Enterprise Value = 339.05b USD (102.12b + Debt 250.63b - CCE 13.70b)
Interest Coverage Ratio = 1.22 (Ebit TTM 21.01b / Interest Expense TTM 17.21b)
FCF Yield = -0.36% (FCF TTM -1.23b / Enterprise Value 339.05b)
FCF Margin = -1.61% (FCF TTM -1.23b / Revenue TTM 76.08b)
Net Margin = 1.11% (Net Income TTM 841.0m / Revenue TTM 76.08b)
Gross Margin = 31.50% ((Revenue TTM 76.08b - Cost of Revenue TTM 52.11b) / Revenue TTM)
Gross Margin QoQ = 37.06% (prev 38.73%)
Tobins Q-Ratio = 0.67 (Enterprise Value 339.05b / Total Assets 506.07b)
Interest Expense / Debt = 1.81% (Interest Expense 4.55b / Debt 250.63b)
Taxrate = 11.27% (134.0m / 1.19b)
NOPAT = 18.64b (EBIT 21.01b * (1 - 11.27%))
Current Ratio = 1.13 (Total Current Assets 74.61b / Total Current Liabilities 65.93b)
Debt / Equity = 5.38 (Debt 250.63b / totalStockholderEquity, last quarter 46.60b)
Debt / EBITDA = 7.69 (Net Debt 236.93b / EBITDA 30.83b)
Debt / FCF = -193.2 (out of range, set to none) (Net Debt 236.93b / FCF TTM -1.23b)
Total Stockholder Equity = 46.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.17% (Net Income 841.0m / Total Assets 506.07b)
RoE = 1.83% (Net Income TTM 841.0m / Total Stockholder Equity 46.08b)
RoCE = 7.08% (EBIT 21.01b / Capital Employed (Equity 46.08b + L.T.Debt 250.63b))
RoIC = 6.51% (NOPAT 18.64b / Invested Capital 286.57b)
WACC = 5.22% (E(102.12b)/V(352.75b) * Re(14.07%) + D(250.63b)/V(352.75b) * Rd(1.81%) * (1-Tc(0.11)))
Discount Rate = 14.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.26%
Fair Price DCF = unknown (Cash Flow -1.23b)
EPS Correlation: 13.61 | EPS CAGR: 136.2% | SUE: -0.78 | # QB: 0
Revenue Correlation: -84.19 | Revenue CAGR: -8.97% | SUE: 0.61 | # QB: 0

Additional Sources for BN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle